Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AstraZeneca PLC - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AZN
Nasdaq
2830
www.astrazeneca.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AstraZeneca PLC
Sector Update: Health Care Stocks Retreat Late Afternoon
- Mar 21st, 2025 7:49 pm
Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals
- Mar 21st, 2025 4:26 pm
Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?
- Mar 21st, 2025 3:30 pm
AstraZeneca to invest £2bn in Beijing amid China investigation
- Mar 21st, 2025 2:39 pm
Micron, Johnson & Johnson, AstraZeneca: Top Stocks
- Mar 21st, 2025 2:19 pm
AstraZeneca to Invest $2.5 Billion in China Amid Probes
- Mar 21st, 2025 1:25 pm
AstraZeneca deepens China investment; Editas loses CFO to Dyne
- Mar 21st, 2025 12:15 pm
AstraZeneca Invests $2.5 Billion in Beijing Hub Amid Probe
- Mar 21st, 2025 11:48 am
AstraZeneca to invest $2.5bn in China after scandal
- Mar 21st, 2025 11:30 am
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals
- Mar 21st, 2025 11:03 am
Here’s Why Parnassus Growth Equity Fund Decided to Sell AstraZeneca PLC (AZN)
- Mar 20th, 2025 12:58 pm
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
- Mar 19th, 2025 10:15 pm
AstraZeneca (AZN): Among the Best Diabetes Stocks to Buy According to Billionaires
- Mar 19th, 2025 2:18 pm
3 UK Stocks Estimated To Be Trading At Discounts Of Up To 48.5%
- Mar 19th, 2025 6:07 am
Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?
- Mar 18th, 2025 12:47 pm
AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III
- Mar 18th, 2025 12:18 pm
Stoke CEO exits; Medicare drug price talks advance
- Mar 18th, 2025 12:05 pm
AstraZeneca and Alteogen agree on ALT-B4 platform tech
- Mar 18th, 2025 9:32 am
Sector Update: Health Care Stocks Rise Late Afternoon
- Mar 17th, 2025 7:58 pm
European Equities Rise in Monday Trading; AstraZeneca to Acquire EsoBiotec for Up to $1 Billion
- Mar 17th, 2025 3:58 pm
Scroll